Malcolm H Hermele is a Union, New Jersey based male rheumatologist who is specialized in Rheumatology. Active license number of Malcolm H Hermele is 25MA02501400 in New Jersey. Malcolm H Hermele treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Malcolm H Hermele speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Male
Practice Address:
2333 Morris Ave, Suite A-117, Union, New Jersey, 07083-5714
Phone:
908-687-7250
Fax:
908-964-0188
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1457409286
NPI Enumeration Date:
08 Jan, 2007
NPI Last Update On:
17 Dec, 2010
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Malcolm H Hermele are as mentioned below.
License Number
Specialization
State
Status
25MA02501400
New Jersey
Primary
25MA02501400
Rheumatology
New Jersey
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2333 Morris Ave, Suite A-117 Union, New Jersey
Zip:
07083-5714
Phone Number:
908-687-7250
Fax Number:
908-964-0188
Patients can reach Malcolm H Hermele at 2333 Morris Ave, Suite A-117, Union, New Jersey or can call to book an appointment on 908-687-7250. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.